These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1010 related articles for article (PubMed ID: 19837467)

  • 1. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
    Malam Y; Loizidou M; Seifalian AM
    Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticles for drug delivery in cancer treatment.
    Haley B; Frenkel E
    Urol Oncol; 2008; 26(1):57-64. PubMed ID: 18190833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle technologies for cancer therapy.
    Alexis F; Pridgen EM; Langer R; Farokhzad OC
    Handb Exp Pharmacol; 2010; (197):55-86. PubMed ID: 20217526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles for delivery of chemotherapeutic agents to tumors.
    Vijayaraghavalu S; Raghavan D; Labhasetwar V
    Curr Opin Investig Drugs; 2007 Jun; 8(6):477-84. PubMed ID: 17621878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance].
    Chen JN; Shen Q; Li SS
    Yao Xue Xue Bao; 2009 Apr; 44(4):333-7. PubMed ID: 19545047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porous nanoparticles in drug delivery systems.
    Arayne MS; Sultana N
    Pak J Pharm Sci; 2006 Apr; 19(2):158-69. PubMed ID: 16751130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in tumor vasculature targeting using liposomal drug delivery systems.
    Abu Lila AS; Ishida T; Kiwada H
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1297-309. PubMed ID: 19780711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoscale particulate systems for multidrug delivery: towards improved combination chemotherapy.
    Liboiron BD; Mayer LD
    Ther Deliv; 2014 Feb; 5(2):149-71. PubMed ID: 24483194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal drug delivery systems--clinical applications.
    Goyal P; Goyal K; Vijaya Kumar SG; Singh A; Katare OP; Mishra DN
    Acta Pharm; 2005 Mar; 55(1):1-25. PubMed ID: 15907221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour targeting: biological factors and formulation advances in injectable lipid nanoparticles.
    Shenoy VS; Vijay IK; Murthy RS
    J Pharm Pharmacol; 2005 Apr; 57(4):411-22. PubMed ID: 15831200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance in cancer therapy: role of the microenvironment.
    Galmarini CM; Galmarini FC
    Curr Opin Investig Drugs; 2003 Dec; 4(12):1416-21. PubMed ID: 14763126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of anticancer drugs.
    Zee-Cheng RK; Cheng CC
    Methods Find Exp Clin Pharmacol; 1989; 11(7-8):439-529. PubMed ID: 2689812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle-based combination therapy toward overcoming drug resistance in cancer.
    Hu CM; Zhang L
    Biochem Pharmacol; 2012 Apr; 83(8):1104-11. PubMed ID: 22285912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles.
    Alavi M; Hamidi M
    Drug Metab Pers Ther; 2019 Feb; 34(1):. PubMed ID: 30707682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-sensitive liposomes--principle and application in cancer therapy.
    Karanth H; Murthy RS
    J Pharm Pharmacol; 2007 Apr; 59(4):469-83. PubMed ID: 17430630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active targeting schemes for nanoparticle systems in cancer therapeutics.
    Byrne JD; Betancourt T; Brannon-Peppas L
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1615-26. PubMed ID: 18840489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New chimeric advanced Drug Delivery nano Systems (chi-aDDnSs) as doxorubicin carriers.
    Gardikis K; Tsimplouli C; Dimas K; Micha-Screttas M; Demetzos C
    Int J Pharm; 2010 Dec; 402(1-2):231-7. PubMed ID: 20934501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy.
    Gindy ME; Prud'homme RK
    Expert Opin Drug Deliv; 2009 Aug; 6(8):865-78. PubMed ID: 19637974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.